Hancock Jaffe Laboratories, Inc. logo
Hancock Jaffe Laboratories, Inc. HJLI

Hancock Jaffe Laboratories, Inc. Deferred Revenue 2011-2025 | HJLI

Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.
Features of the metric
  • Sources of future cash inflows
    A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability.
  • Assessment of operational stability
    Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages.
  • Risks and obligations
    Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results.
  • Analysis of liquidity and cash flow
    Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks.
  • Impact on company valuation
    In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).

Annual Deferred Revenue Hancock Jaffe Laboratories, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
33 33 K 33 K 103 K - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
103 K 33 42.4 K

Deferred Revenue of other stocks in the Medical devices industry

Issuer Deferred Revenue Price % 24h Market Cap Country
Apyx Medical Corporation Apyx Medical Corporation
APYX
500 K $ 3.86 -3.26 % $ 134 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
16 K - 37.08 % $ 85.7 M usaUSA
Abiomed Abiomed
ABMD
24.3 M - - $ 17.2 B usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
508 K - - $ 1.77 B usaUSA
Cutera Cutera
CUTR
10.4 M - -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
621 K - - $ 10.2 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
424 K - -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
47.8 M $ 307.92 -1.93 % $ 8.69 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
88 K - - $ 475 M usaUSA
Acutus Medical Acutus Medical
AFIB
401 K - -26.83 % $ 2.62 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
438 M $ 45.13 -2.67 % $ 6.72 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
563 K - 3.58 % $ 2.21 M usaUSA
Conformis Conformis
CFMS
215 K - - $ 16.4 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
306 M $ 92.34 0.64 % $ 136 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
1.45 M - -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
6.64 M $ 2.56 8.94 % $ 95.5 M franceFrance
Invacare Corporation Invacare Corporation
IVC
2.28 M - - $ 24.7 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
2.11 M - 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
2.4 M $ 0.92 -4.72 % $ 14.8 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
2.26 M $ 96.35 -1.06 % $ 1.22 B usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
732 K - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
13.3 K - - $ 462 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
10.8 M $ 62.79 -1.82 % $ 3.41 B britainBritain
Pulmonx Corporation Pulmonx Corporation
LUNG
135 K $ 2.53 0.86 % $ 99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
150 K - 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
137 K - - $ 955 M usaUSA
InMode Ltd. InMode Ltd.
INMD
11.9 M $ 14.56 0.76 % $ 1.15 B israelIsrael
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
127 M $ 9.88 0.05 % $ 709 M israelIsrael
Myomo Myomo
MYO
2.51 K $ 1.06 -1.85 % $ 7.47 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
335 K - -0.97 % $ 54.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
10.5 M $ 13.41 -4.56 % $ 1.03 B usaUSA
Align Technology Align Technology
ALGN
1.33 B $ 165.15 0.78 % $ 12.4 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
82.3 M $ 1.07 -3.18 % $ 110 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
2.12 M $ 12.81 -1.23 % $ 346 M usaUSA
FONAR Corporation FONAR Corporation
FONR
4.29 M $ 14.86 -0.03 % $ 97.4 M usaUSA
AxoGen AxoGen
AXGN
14 K $ 30.33 1.15 % $ 1.34 B usaUSA
LENSAR LENSAR
LNSR
1.68 M $ 11.48 -0.17 % $ 132 M usaUSA